Sky Oak Wealth, LLC Alaunos Therapeutics, Inc. Transaction History

Sky Oak Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$1.09 - $1.89 $92,067 - $159,640	-84,466 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$2.63 - $3.67 $3,363 - $4,693	-1,279 Reduced 1.49%	84,466 $223,000
Q1 2021 Apr 29, 2021	SELL	$2.82 - $5.6 $15,580 - $30,939	-5,525 Reduced 6.05%	85,745 $301,000
Q4 2020 Feb 02, 2021	BUY	$2.09 - $3.09 $190,754 - $282,024	91,270 New	91,270 $230,000

106K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $151M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky Oak Wealth, LLC with notifications on news.